Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Markets
Screener
News
About

COR - Cencora, Inc. Latest News | Finranks

Home

COR

C

Cencora, Inc. (COR)

NYQ – Real Time Price. Currency in USD

312.45

-5.58 (-1.75%)

At close: Mar 27, 2026, 4:00 PM EDT

312.59

+0.14 (0.04%)

After-hours: Mar 27, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal

COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal

Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care market.

Cencora to buy retina business of EyeSouth Partners for $1.1 billion

Cencora to buy retina business of EyeSouth Partners for $1.1 billion

Drug distributor Cencora ‌said on Monday it would ⁠buy the retina business of eye care network EyeSouth ‌Partners ⁠for $1.1 billion, expanding its eye ⁠care unit.

Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business

Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of EyeSouth Partners will join Cencora's Retina Consultants of America (“RCA”), a leading management services organization (MSO). “Driven by a commitment to empower ophthalmologists, EyeSouth Partners has built a strong regional network of physicians.

Here's Why You Should Hold Cencora Stock in Your Portfolio for Now

Here's Why You Should Hold Cencora Stock in Your Portfolio for Now

Cencora's strong U.S. growth, MSO strategy, and raised outlook support long-term potential, but competition and customer losses remain key risks.

Cencora Announces Financial Leadership Transition

Cencora Announces Financial Leadership Transition

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026. Cencora has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates. Mr. Cleary will assist in the search process and will serve in an advisory capacity through the end of 2026 to help ensure a smooth transition. Mr. Cleary, 62, has served as Cen.

Cencora, Inc. (COR) Presents at Leerink Global Healthcare Conference 2026 Transcript

Cencora, Inc. (COR) Presents at Leerink Global Healthcare Conference 2026 Transcript

Cencora, Inc. (COR) Presents at Leerink Global Healthcare Conference 2026 Transcript

Cencora, Inc. (COR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Cencora, Inc. (COR) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Videos

No Data

There is no data to display

Press releases

Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business

Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina Business

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of EyeSouth Partners will join Cencora's Retina Consultants of America (“RCA”), a leading management services organization (MSO). “Driven by a commitment to empower ophthalmologists, EyeSouth Partners has built a strong regional network of physicians.

Cencora Announces Financial Leadership Transition

Cencora Announces Financial Leadership Transition

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026. Cencora has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates. Mr. Cleary will assist in the search process and will serve in an advisory capacity through the end of 2026 to help ensure a smooth transition. Mr. Cleary, 62, has served as Cen.

Covetrus and MWI Animal Health to Merge

Covetrus and MWI Animal Health to Merge

CONSHOHOCKEN, Pa. & PORTLAND, Maine--(BUSINESS WIRE)--Cencora (NYSE: COR) and Covetrus, a global animal health technology and services company, today announced that they have entered into a definitive agreement under which Covetrus and MWI Animal Health (MWI) will merge, creating a combined company offering a comprehensive animal health platform. “Our mission has always been to empower veterinary practices to work smarter and deliver better care,” said Ben Wolin, President and Chief Executive O.

Cencora Closes $3.0 Billion Senior Notes Offering

Cencora Closes $3.0 Billion Senior Notes Offering

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500 million aggregate principal amount of its 3.950% Senior Notes due February 13, 2029 (the “2029 Notes”), $500 million aggregate principal amount of its 4.250% Senior Notes due November 15, 2030 (the “2030 Notes”), $500 million aggregate principal amount of its 4.600% Senior Notes due February 13, 2033 (the “2033 Notes”), $1.0 billion aggregate principal amount of its 4.900% Se.